Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer

Yazar: Santoro, Ana B, Vargens, Daniela D, Barros Filho, Mateus de Camargo, Bulzico, Daniel A, Kowalski, Luiz Paulo, Meirelles, Ricardo M R, Paula, Daniela P, Neves, Ronaldo R S, Pessoa, Cencita N, Struchine, Claudio J, Suarez-Kurtz, Guilherme
Yayımlandı Br J Clin Pharmacol (2014)